Sequencing and Genomic Technologies (SGT) is a basic science research core affiliated with the Duke Cancer Institute (DCI) that offers a full range of state-of-the-art genomic services. For answers to common questions, please visit our Frequently Asked Questions and Policies.
Director Devi Swain Lenz is available for project consultations.
News & Announcements
Oxford Nanopore Technology GridION: Putting More Bases in Their Places
The Sequencing and Genomic Technologies (SGT) Core Facility recently added an Oxford Nanopore GridION long-read sequencer to its arsenal. The GridION provides cost-effective, ultra-long sequencing reads of hundreds of kilobases to help answer research questions that short read sequencers cannot.